• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Prostate Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multi-centre Study. Lancet 2020;395:1208-16: PSMA Positron Emission Tomography: One Tracer Fixes Them All!

作者信息

Lopci Egesta, Lazzeri Massimo

机构信息

Nuclear Medicine Department, Humanitas Clinical and Research Hospital - IRCCS, Rozzano, Italy.

Urology Department, Humanitas Clinical and Research Hospital - IRCCS, Rozzano, Italy.

出版信息

Eur Urol. 2020 Sep;78(3):e131-e132. doi: 10.1016/j.eururo.2020.06.054. Epub 2020 Jul 9.

DOI:10.1016/j.eururo.2020.06.054
PMID:32653324
Abstract
摘要

相似文献

1
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Prostate Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multi-centre Study. Lancet 2020;395:1208-16: PSMA Positron Emission Tomography: One Tracer Fixes Them All!
Eur Urol. 2020 Sep;78(3):e131-e132. doi: 10.1016/j.eururo.2020.06.054. Epub 2020 Jul 9.
2
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208-16.回复：迈克尔·S·霍夫曼、内森·劳伦楚克、罗斯林·J·弗朗西斯等。根治性手术或放疗前高危癌症患者的前列腺特异性膜抗原PET-CT检查（proPSMA）：一项前瞻性、随机、多中心研究。《柳叶刀》2020年；395卷：1208 - 16页。
Eur Urol Oncol. 2020 Oct;3(5):713. doi: 10.1016/j.euo.2020.06.013. Epub 2020 Jul 18.
3
Re: Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Prostate Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multi-centre Study.
Eur Urol. 2020 Sep;78(3):470-471. doi: 10.1016/j.eururo.2020.04.051. Epub 2020 May 1.
4
Re: Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Prostate Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multi-centre Study.回复：前列腺特异性膜抗原PET-CT在根治性手术或放疗前高危前列腺癌患者中的应用（proPSMA）：一项前瞻性、随机、多中心研究
Eur Urol. 2020 Oct;78(4):633. doi: 10.1016/j.eururo.2020.06.017. Epub 2020 Jul 2.
5
Re: Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Prostate Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multicentre Study.
Eur Urol. 2021 Sep;80(3):385. doi: 10.1016/j.eururo.2021.05.037. Epub 2021 Jun 24.
6
A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.一项前瞻性随机多中心研究，评估镓-68 前列腺特异性膜抗原（PSMA）PET/CT 成像在根治性手术或放疗前对高危前列腺癌分期的影响（proPSMA 研究）：临床试验方案。
BJU Int. 2018 Nov;122(5):783-793. doi: 10.1111/bju.14374. Epub 2018 Jun 3.
7
Commentary on "Prostate-Specific Membrane Antigen PET-CT in Patients With High-Risk Prostate Cancer Before Curative-Intent Surgery or Radiotherapy (proPSMA): a Prospective, Randomised, Multicentre Study".关于“前列腺特异性膜抗原PET-CT在根治性手术或放疗前的高危前列腺癌患者中的应用（proPSMA）：一项前瞻性、随机、多中心研究”的评论
AJR Am J Roentgenol. 2021 Feb;216(2):310. doi: 10.2214/AJR.20.23666. Epub 2020 Jul 29.
8
Re: Prostate-Specific Membrane Antigen PET-CT in Patients with High-Risk Prostate Cancer before Curative-Intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multicentre Study.关于：根治性手术或放疗前高危前列腺癌患者的前列腺特异性膜抗原PET-CT检查（proPSMA）：一项前瞻性、随机、多中心研究。
J Urol. 2020 Oct;204(4):878-879. doi: 10.1097/JU.0000000000001220.01. Epub 2020 Jul 27.
9
Clinical impact of Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate-specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach.镓标记前列腺特异性膜抗原（PSMA）正电子发射断层扫描/计算机断层扫描（PET/CT）在根治性治疗后前列腺特异性抗原升高的前列腺癌患者中的临床影响：多学科方法的初步分析
BJU Int. 2017 Aug;120(2):197-203. doi: 10.1111/bju.13739. Epub 2017 Jan 4.
10
Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature.前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描（PSMA-PET/CT）引导下的立体定向消融体部放射治疗寡转移前列腺癌：单机构经验及已发表文献综述
BJU Int. 2019 Nov;124 Suppl 1:19-30. doi: 10.1111/bju.14886. Epub 2019 Sep 11.